Hot Flashes and Neurovascular Function in Women
Launched by MAYO CLINIC · Jan 3, 2022
Trial Information
Current as of July 23, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how hot flashes during menopause might be linked to heart health issues in women. Researchers believe that the way our blood vessels and nerves work together could explain why women who have hot flashes are at a higher risk for conditions like high blood pressure and other heart diseases. By understanding this connection better, the study hopes to improve health outcomes for women experiencing these symptoms.
To participate in this trial, women aged between 14 and 21 who do not smoke, are not obese, and have at least one ovary can apply. It's important that participants do not have any existing heart disease and are not taking medications that affect heart function. There are no specific exclusions, so if you meet the criteria, you may be eligible to join. Participants will be helping to uncover important information that could benefit women's health, particularly regarding managing hot flashes and preventing cardiovascular issues.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Non-smokers.
- • Non-obese.
- • Have at least one ovary.
- • Free from cardiovascular disease.
- • Not taking medications influencing cardiovascular function.
- Exclusion Criteria:
- • - None.
About Mayo Clinic
Mayo Clinic is a renowned nonprofit medical practice and research institution dedicated to providing comprehensive healthcare and advancing medical knowledge through innovative research and education. With a commitment to patient-centered care, Mayo Clinic conducts numerous clinical trials aimed at exploring new therapies and improving treatment outcomes across various disciplines. Leveraging a multidisciplinary approach, the institution collaborates with leading experts and cutting-edge technology to ensure rigorous scientific standards and ethical practices in all its research endeavors. Through its trials, Mayo Clinic seeks to translate breakthroughs in science into tangible benefits for patients, fostering advancements in medicine that enhance health and quality of life.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Rochester, Minnesota, United States
Patients applied
Trial Officials
Sarah Baker, PhD
Principal Investigator
Mayo Clinic
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials